These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9403225)

  • 1. Effect of citalopram on brain serotonin release in experimental hepatic encephalopathy: implications for thymoleptic drug safety in liver insufficiency.
    Bergqvist PB; Wikell C; Hjorth S; Apelqvist G; Bengtsson F
    Clin Neuropharmacol; 1997 Dec; 20(6):511-22. PubMed ID: 9403225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic and kinetic effects of chronic citalopram treatment in experimental hepatic encephalopathy.
    Apelqvist G; Wikell C; Carlsson B; Hjorth S; Bergqvist PB; Ahlner J; Bengtsson F
    Clin Neuropharmacol; 2000; 23(6):304-17. PubMed ID: 11575864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potassium-evoked neuronal release of serotonin in experimental chronic portal-systemic encephalopathy.
    Bergqvist PB; Hjorth S; Apelqvist G; Bengtsson F
    Metab Brain Dis; 1997 Sep; 12(3):193-202. PubMed ID: 9346468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effects of L-tryptophan on brain extracellular 5-HT and 5-HIAA levels in chronic experimental portal-systemic encephalopathy.
    Bergqvist PB; Hjorth S; Apelqvist G; Bengtsson F
    Metab Brain Dis; 1996 Sep; 11(3):269-78. PubMed ID: 8869946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain monoamine output alterations after a single venlafaxine challenge in experimental hepatic encephalopathy.
    Wikell C; Bergqvist PB; Hjorth S; Apelqvist G; Björk H; Bengtsson F
    Clin Neuropharmacol; 1998; 21(5):296-306. PubMed ID: 9789710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p-Chloroamphetamine- and d-fenfluramine-induced brain serotonin release in experimental portal-systemic encephalopathy.
    Bergqvist PB; Hjorth S; Wikell C; Apelqvist G; Bengtsson F
    Metab Brain Dis; 1997 Sep; 12(3):229-36. PubMed ID: 9346471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoreceptor antagonists enhance the effect of the reuptake inhibitor citalopram on extracellular 5-HT: this effect persists after repeated citalopram treatment.
    Gundlah C; Hjorth S; Auerbach SB
    Neuropharmacology; 1997; 36(4-5):475-82. PubMed ID: 9225272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of chronic treatment with escitalopram or citalopram on extracellular 5-HT in the prefrontal cortex of rats: role of 5-HT1A receptors.
    Ceglia I; Acconcia S; Fracasso C; Colovic M; Caccia S; Invernizzi RW
    Br J Pharmacol; 2004 Jun; 142(3):469-78. PubMed ID: 15148253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of halving the dose of venlafaxine to adjust for putative pharmacokinetic and pharmacodynamic changes in an animal model of chronic hepatic encephalopathy.
    Wikell C; Kugelberg FC; Hjorth S; Apelqvist G; Bengtsson F
    Clin Neuropharmacol; 2001; 24(6):324-33. PubMed ID: 11801807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered open-field behavior in experimental chronic hepatic encephalopathy after single venlafaxine and citalopram challenges.
    Apelqvist G; Wikell C; Hindfelt B; Bergqvist PB; Andersson G; Bengtsson F
    Psychopharmacology (Berl); 1999 Apr; 143(4):408-16. PubMed ID: 10367559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of chronic administration of the selective serotonin (5-HT) uptake inhibitor citalopram on extracellular 5-HT and apparent autoreceptor sensitivity in rat forebrain in vivo.
    Auerbach SB; Hjorth S
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 352(6):597-606. PubMed ID: 9053730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WAY100635-induced augmentation of the 5-HT-elevating action of citalopram: relative importance of the dose of the 5-HT1A (auto)receptor blocker versus that of the 5-HT reuptake inhibitor.
    Hjorth S; Westlin D; Bengtsson HJ
    Neuropharmacology; 1997; 36(4-5):461-5. PubMed ID: 9225270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and pharmacodynamic responses to chronic administration of the selective serotonin reuptake inhibitor citalopram in rats.
    Wikell C; Apelqvist G; Carlsson B; Hjorth S; Bergqvist PB; Kugelberg FC; Ahlner J; Bengtsson F
    Clin Neuropharmacol; 1999; 22(6):327-36. PubMed ID: 10626092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.
    van Amsterdam C; Seyfried CA
    Psychopharmacology (Berl); 2014 Jun; 231(12):2547-58. PubMed ID: 24419272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram.
    Arborelius L; Nomikos GG; Hertel P; Salmi P; Grillner P; Höök BB; Hacksell U; Svensson TH
    Naunyn Schmiedebergs Arch Pharmacol; 1996 May; 353(6):630-40. PubMed ID: 8738296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of organotypic raphe slice cultures to investigate the effects of sustained exposure to selective 5-HT reuptake inhibitors on 5-HT release.
    Nagayasu K; Yatani Y; Kitaichi M; Kitagawa Y; Shirakawa H; Nakagawa T; Kaneko S
    Br J Pharmacol; 2010 Dec; 161(7):1527-41. PubMed ID: 20698856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic model of acute autoinhibitory feedback action after administration of SSRIs in rats: application to escitalopram-induced effects on brain serotonin levels.
    Bundgaard C; Larsen F; Jørgensen M; Gabrielsson J
    Eur J Pharm Sci; 2006 Dec; 29(5):394-404. PubMed ID: 17014998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HT1A autoreceptors and the mode of action of selective serotonin reuptake inhibitors (SSRI).
    Hjorth S; Auerbach SB
    Behav Brain Res; 1996; 73(1-2):281-3. PubMed ID: 8788519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additive effect of rimonabant and citalopram on extracellular serotonin levels monitored with in vivo microdialysis in rat brain.
    Ortega JE; Gonzalez-Lira V; Horrillo I; Herrera-Marschitz M; Callado LF; Meana JJ
    Eur J Pharmacol; 2013 Jun; 709(1-3):13-9. PubMed ID: 23562616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ammonium acetate challenge in experimental chronic hepatic encephalopathy induces a transient increase of brain 5-HT release in vivo.
    Bergqvist PB; Hjorth S; Audet RM; Apelqvist G; Bengtsson F; Butterworth RF
    Eur Neuropsychopharmacol; 1996 Nov; 6(4):317-22. PubMed ID: 8985716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.